Related Experiment Videos
[Human costs of tobacco dependence].
Marco Vannotti1, France Priez, Claude Jeanrenaud
1Policlinique médicale universitaire (PMU), Service de Psychiatrie de Liaison, Lausanne, Suisse.
Revue Medicale De La Suisse Romande
|April 30, 2002
Summary
This study values the quality of life impact of smoking-related diseases in Switzerland. Understanding these human costs can improve smoking cessation strategies.
Area of Science:
- Health Economics
- Public Health
- Behavioral Science
Context:
- Smoking remains a significant public health issue globally.
- Quantifying the burden of smoking-related diseases is crucial for policy-making.
- Previous research has not fully captured the public's valuation of quality-of-life impacts.
Purpose:
- To estimate the monetary value the general population attributes to the quality-of-life consequences of smoking-related diseases.
- To provide economic insights into the perceived burden of smoking.
- To inform the development of more effective smoking cessation interventions.
Summary:
- A Swiss study led by economists and physicians estimated the public's monetary valuation of quality-of-life impacts from smoking-related diseases.
- The research utilized economic methodologies to assess the perceived human costs associated with tobacco use.
- Findings offer a novel perspective on how the general population values health and well-being in the context of smoking.
Impact:
- This economic valuation can enhance understanding of smokers' concerns and beliefs.
- Results may contribute to the design of improved, evidence-based smoking cessation strategies in primary care settings.
- The study provides a framework for valuing health-related quality of life in economic assessments.